Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03063372

Pomegranate Supplementation and Well-Being Among Medical Students and Residents

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Mississippi Medical Center · Academic / Other
Sex
All
Age
21 Years – 40 Years
Healthy volunteers
Accepted

Summary

Medical students and residents have high rates of mental distress and burnout related to the intellectual and time demands of their training. Research shows that physiological stress on the body can be a result of fatigue and high stress work, and is associated with experiences related to mental distress. Pomegranate is a fruit that is known to contain a variety of antioxidant substances that can reduce physiological stress. This study will look at the potential for pomegranate supplementation to reduce physiological stress and improve well-being in medical students and residents.

Detailed description

This is a pilot study to investigate the feasibility of conducting a randomized trial of pomegranate supplementation in medical students and residents, and to see whether there is evidence of an effect on reported emotional and physical well-being. Phase 1 will be a pilot with 10 participants in which all will receive the pomegranate supplement for 28 days. In phase 2, we will randomize 40 participants (1:1) to receive either the pomegranate supplement or a placebo. For both phases, we will measure self reported emotional and physical well-being using several questionnaires, and we will conduct laboratory testing for measures of oxidative stress and inflammatory biomarkers in blood, and for a metabolite of pomegranate in urine.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPomella pomegranate extractParticipants will take a 500 mg capsule of pomegranate extract twice daily for 28 days.
OTHERPlaceboParticipants will take a gelatin placebo twice daily for 28 days.

Timeline

Start date
2017-02-28
Primary completion
2027-02-01
Completion
2027-02-01
First posted
2017-02-24
Last updated
2025-04-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03063372. Inclusion in this directory is not an endorsement.